Mori Memorial Foundation Issues GPCI–2024 and GPCI–Financial Centers Reports:
10.12.2024 04:00:00 CET | Business Wire | Press release
— Post-Pandemic Economic Recovery and International Tourism Expansion Impact Rankings —
The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today released its Global Power City Index (GPCI) 2024 report on the overall strength of the world’s 48 major cities. For the second time, the report additionally includes the 'GPCI–Financial Centers' index. This index reflects the growing importance of measures taken by major cities to enhance their status as international financial centers, capturing changes in their financial and business environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241209714811/en/
The 48 major cities evaluated in Mori Memorial Foundation’s GPCI–2024 Report (Graphic: Business Wire)
More than 18 months have elapsed since the World Health Organization declared an end to the COVID-19 pandemic in May 2023. With the resurgence of economic activity, mobility and the expansion of international tourism, this year’s GPCI rankings also reflect global trends influenced by the escalating issues of inflation and climate change.
There was no change in the top five rankings (London in 1st place, New York in 2nd, Tokyo in 3rd, Paris in 4th, and Singapore in 5th). However, Tokyo, Paris, and Singapore made substantial strides, closing in on New York's position; all three of those cities saw improvements in indicators related to “Cultural Interaction,” such as the number of foreign tourists and visitor amenities, including the number of hotel rooms. The decision to host the 2024 Summer Olympics in Paris, and the growth of international tourism in Tokyo and Singapore, which had been delayed due to cautious border control measures, were reflected in the results.
GPCI–2024 Highlights
London (1st)
While the momentum generated by London’s recovery from the pandemic eased compared to last year, the city’s overall score increased slightly, ensuring it maintained its top position. In addition to its overall lead in the “Cultural Interaction” function, London newly secured the first place in “Accessibility.” The city’s scores in “Livability” improved in indicators including “Working Environment,” rising to 6th place in this category. Continued improvements in London’s environmental indicators could potentially lead to a further increase in the city’s overall score.
New York (2nd)
New York held onto its second place, though its overall score declined from last year, widening the gap with London. It continues to excel in key areas, securing first place in both the "Economy" and "R&D" categories. The city's rank in the "Accessibility" function improved, particularly in the area of "Ease of Mobility by Bicycle." However, with the city ranked down in the 30s for both "Livability" and "Environment," there remains significant potential for improvement.
Tokyo (3rd)
Tokyo made substantial gains in its overall score this year, closing in on New York, with contributing factors including the rise in the number of foreign visitors taking advantage of a weaker yen. However, it is being closely pursued by Paris, which sits in fourth place, indicating tight competition. Tokyo saw improvements in four functions: “R&D,” “Cultural Interaction,” “Livability,” and “Accessibility,” achieving the largest score increase among all 48 cities this year. Despite these advancements, the city’s “Economy” function, which has been in relative decline, is noted as an area needing improvement.
Paris (4th)
Paris came within striking distance of Tokyo in third place. Nevertheless, the city saw a dramatic increase in its “Cultural Interaction” score, backed by its hosting of the Olympics, marking the largest increase in this category among the 48 cities. The full effects of the city’s hosting of the Olympics, such as an increase in the number of foreign visitors, will be reflected in GPCI-2025, suggesting the possibility of further score improvements.
Singapore (5th)
Although its recovery from the pandemic had been somewhat slow, Singapore managed to further boost its "Air Transport Capacity" ratings and enhance its performance in the "Cultural Interaction" and "Livability" functions, thereby maintaining its 5th place overall. In "Economy," it made significant gains in "GDP per Capita;" however, it saw a decline in areas previously considered its strengths, such as "Variety of Workplace Options," "Workstyle Flexibility" and "Number of Retail Shops.”
Seoul (6th)
Seoul made positive strides this year, moving up one place in the rankings thanks to improved scores in “R&D,” “Accessibility” and “Livability.” This was despite a decrease in the city’s overall score, due partially to a significant drop in its “Cultural Interaction” ratings. The city made notable progress in the “Commitment to Climate Action” indicator, which newly evaluates the frequency with which a city is selected for the CDP A List, achieving a substantial increase in ranking. Seoul's rise in the rankings was partly the result of Amsterdam, previously in 6th place, suffering falling ratings across five functions, excluding “Environment.”
Madrid (10th)
Madrid made a notable leap this year, climbing four places and re-entering the top 10 for the first time in three years. In addition to maintaining its second place in "Livability," the city saw improvements in "R&D," "Environment" and "Accessibility." Significant progress was observed in "Number of International Students" (R&D), "Commitment to Climate Action" and "Urban Greenery" (Environment), as well as in "Travel Time to Airports" and "Commuting Time" (Accessibility). However, there was a decline in the city’s ratings for "Variety of Workplace Options" and "Housing Rent."
Shanghai (11th)
In the wake of the lifting of border controls imposed during the COVID pandemic, Shanghai moved up from 15th to 11th place. This shift was largely influenced by the recovery of international travel. The city saw an increase in its “Number of Foreign Visitors” (Cultural Interaction) ranking as well as in “Number of Air Passengers,” which resulted in an improvement in “Accessibility,” pushing its ranking in this area from 9th up to 7th. Additionally, Shanghai's 12th position in “R&D” was strengthened by higher evaluations for its “World's Top Universities.”
Key Finding by Functions
Economy
Dublin and Copenhagen made significant strides in this category, fueled by a continued surge in their “GDP Growth Rate” scores. Dublin moved up from 6th to 3rd place, while Copenhagen leaped from 19th to 9th place.
R&D
American cities occupied five of the top 10 spots, reflecting their ongoing strengths. Among Asian cities, Tokyo, Seoul and Hong Kong made it into the top 10. Tokyo advanced one rank to 3rd place, a position it reclaimed after four years. Both Tokyo and Dubai, the latter now in 32nd place, saw significant score increases in the "Number of Startups" category.
Cultural Interaction
While London continues to hold its dominant position, Paris and Tokyo have made notable strides. Paris, moving up from 3rd to 2nd place, and Tokyo, rising from 5th to 3rd, saw a significant increase in scores including “Number of Foreign Visitors.”
Livability
The top four cities remain unchanged, with Paris in 1st place, followed by Madrid, Tokyo and Barcelona. Osaka, Milan, Helsinki and Kuala Lumpur newly entered the top 10. Changes in rankings were influenced by indicators such as inflation levels, as well as post-pandemic factors in areas including “Workstyle Flexibility.”
Environment
Eight out of the 10 highest-ranked cities were in Europe, five of which have populations of less than one million (Copenhagen, Stockholm, Helsinki, Zurich and Geneva). Factors such as “Commitment to Climate Action,” incorporating evaluations by the climate change initiative CDP, influenced the rankings.
Accessibility
There was a significant reshuffle of the top ten cities from last year in this category; they are now, in order, London, New York, Paris, Dubai, Tokyo, Frankfurt, Shanghai, Amsterdam, Singapore and Istanbul. This shift can be attributed to changes in the evaluation indicators used, such as the inclusion of the number of bicycle parking spaces and cycle ports under "Ease of Mobility by Bicycle." London in particular stood out in the category of "Cities with Direct International Flights."
GPCI–Financial Centers
The rapid expansion and internationalization of the global financial industry is intensifying competition among major cities, making each city’s status as an international financial center increasingly important. The Mori Memorial Foundation, in addition to its multifaceted evaluation of cities in terms of six functions in the Global Power City Index (GPCI), namely Economy, R&D, Cultural Interaction, Livability, Environment, and Accessibility, has now added the Finance function, which consists of 14 indicators in 4 groups.
New York (1st): the city received high scores across all groups of indicators - Financial Instruments Markets, Financial Intermediaries, Foreign Exchange and Interest Rate Markets, and Highly Skilled Personnel. As in the previous year, it ranked first in terms of “Stock Market Capitalization,” “Stock Market Trading Value,” “World’s Top Asset Managers,” and “International Law Firms.” This year it also ranked first in the “Financial Industry Unicorn Companies” category.
London (2nd): it maintained its position as the city with the highest level of “Foreign Exchange Turnover” and “Interest Rate Derivatives Turnover” in the Foreign Exchange and Interest Rate Markets category, and has a clear lead in this area. It also continued to secure the second-highest ratings for “Highly Skilled Personnel” in the finance sector, after New York.
Tokyo (3rd): Japan’s capital maintained its top ranking in two indicators of the Financial Intermediaries Group function: “World’s Top Insurance Company Headquarters” and “World’s Top Pension Funds.” It also maintained its high rankings for “Stock Market Capitalization” and “Stock Market Trading Value,” achieving 3rd and 4th place respectively. The city improved its ratings in the field of “Financial Instruments Markets,” rising from 9th to 4th position, due in part to an improvement in its score for “Capital Raised Through IPOs,” a category where it rose from 7th to 5th position.
Shanghai (4th): the city maintained its second place ranking in the category of Financial Instruments Markets for the second year in a row, but it fell from 7th to 23rd place in “Financial Industry Unicorn Companies;” it also recorded a reduced score in the specific area of Highly Skilled Personnel.
Beijing (5th): China’s capital city maintained its position in third place in Financial Instruments Markets and secured the top slot in the category of “World’s Top Bank Headquarters.” However, its ratings in its other perceived area of strength, Highly Skilled Personnel, fell with the city dropping from fifth to seventh place in this category.
The full press release can be viewed at https://mori-m-foundation.or.jp/pdf/GPCI2024_release_en.pdf
View source version on businesswire.com: https://www.businesswire.com/news/home/20241209714811/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom